HuGE Literature Finder
Records
1
-
30
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. Lung cancer (Amsterdam, Netherlands) 2021 Jul 159 66-73. Mondaca Sebastian, Lebow Emily S, Namakydoust Azadeh, Razavi Pedram, Reis-Filho Jorge S, Shen Ronglai, Offin Michael, Tu Hai-Yan, Murciano-Goroff Yonina, Xu Chongrui, Makhnin Alex, Martinez Andres, Pavlakis Nick, Clarke Stephen, Itchins Malinda, Lee Adrian, Rimner Andreas, Gomez Daniel, Rocco Gaetano, Chaft Jamie E, Riely Gregory J, Rudin Charles M, Jones David R, Li Mark, Shaffer Tristan, Hosseini Seyed Ali, Bertucci Caterina, Lim Lee P, Drilon Alexander, Berger Michael F, Benayed Ryma, Arcila Maria E, Isbell James M, Li Bob |
| One-step polymerase chain reaction-free nanowire-based plasma cell-free DNA assay to detect EML4-ALK fusion and to monitor resistance in lung cancer. The oncologist 2021 Jul . Lee Youngjoo, Cho Youngnam, Park Eun Young, Park Seong-Yun, Hwang Kum Hui, Han Ji-Yo |
| Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis. Cancer treatment and research communications 2021 Jul 28 100440. Takahara Yutaka, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Taku, Mizuno Shi |
| Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series. The Israel Medical Association journal : IMAJ 2020 Dec 22 (12): 784-787. Peled Michael, Bar Jair, Avni Liat, Chatterji Sumit, Somech Dafna, Dvir Addie, Soussan-Gutman Lior, Onn Am |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
| Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report. Journal of cardiothoracic surgery 2020 Jul 15 (1): 196. Yang Yong, Xie Xiaofeng, Jiang Gening, Liu Hongche |
| Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes. Journal of cancer research and clinical oncology 2020 Jan . Tian Panwen, Liu Yujie, Zeng Hao, Tang Yuan, Lizaso Analyn, Ye Junyi, Shao Lin, Li Yal |
| The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients. Frontiers in oncology 2020 10 726. Liu Shaokun, Huang Tanxiao, Liu Ming, He Wenlong, Zhao YingShen, Yang Lizhen, Long Yingjiao, Zong Dandan, Zeng Huihui, Liu Yuanyuan, Liao Wenting, Duan Jingxian, Gong Subo, Chen Shi |
| Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan. International journal of clinical oncology 2019 Aug . Sakai Kosuke, Kuramoto Joji, Kojima Akitoshi, Nishimura Hiroaki, Kuwabara Yoshiki, Toda Maiko, Kobayashi Yumiko, Kikuchi Satoshi, Hirata Yusuke, Mikami-Saito Yuriko, Mikami Shintaro, Kyoyama Hiroyuki, Moriyama Gaku, Gemma Akihiko, Uematsu Kazutsu |
| Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer. Thoracic cancer 2019 (4): 695-707. Chen Ying, Li Guangjian, Lei Yujie, Yang Kaiyun, Niu Huatao, Zhao Jie, He Rui, Ning Huanqi, Huang Qiubo, Zhou Qinghua, Huang Yunch |
| Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2019 Jan 127 19-24. Yu Yongfeng, Ou Qiuxiang, Wu Xue, Bao Hairong, Ding Yan, Shao Yang W, Lu Sh |
| Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib. Cancer management and research 2019 11 8191-8200. Liang Hongge, Ma Di, Xu Yan, Zhao Jing, Chen Minjiang, Liu Xiaoyan, Zhong Wei, Li Junling, Wang Mengzh |
| The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4-ALK Rearranged Non-small Cell Lung Cancer. Frontiers in oncology 2019 9 880. Lin Yen-Ting, Liu Yi-Nan, Shih Jin-Yu |
| Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion. Genes, chromosomes & cancer 2018 Aug . Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu |
| Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma. Medicine 2018 Jun 97 (26): e11116. Wang Hongyan, Zhang Wen, Wang Kai, Li Xiaofe |
| The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer. Journal of thoracic disease 2018 May 10 (5): 2948-2959. Lv Tangfeng, Zou Qian, Song Zhengbo, Liu Hongbing, Wang Qiming, Song Yo |
| About molecular profile of lung cancer in Tunisian patients. Journal of immunoassay & immunochemistry 2018 39 (1): 99-107. Mezni Faouzi, Mlika Mona, Boussen Hamouda, Ghedira Habib, Fenniche Soraya, Faten Talmoudi, Loriot Marie-An |
| Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer. Oncotarget 2017 Feb . Hu Wentao, Liu Yahui, Chen Ji |
| [Gene Expression and Clinical Characteristics of Molecular Targeted Therapy ?in Non-small Cell Lung Cancer Patients in Shandong]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Jan 20 (1): 14-20. Qiao Xiuli, Ai Dan, Liang Honglu, Mu Dianbin, Guo Qis |
| Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer. OncoTargets and therapy 2017 10 5179-5186. Tufman Amanda, Kahnert Kathrin, Duell Thomas, Kauffmann-Guerrero Diego, Milger Katrin, Schneider Christian, Stump Julia, Syunyaeva Zulfiya, Huber Rudolf Maria, Reu Simo |
| Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers. Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 122-134. Chapman Aaron M, Sun Kathie Y, Ruestow Peter, Cowan Dallas M, Madl Amy |
| [Driven Gene in Patients with Lung Squamous Cell Carcinoma: ?Analysis of Clinicopathologic Characteristics and Prognosis]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2016 Oct 19 (10): 648-652. Zhang Tongtong, Li Junli |
| The expression of SALL4 is significantly associated with EGFR, but not KRAS or EML4-ALK mutations in lung cancer. Journal of thoracic disease 2016 Oct 8 (10): 2682-2688. Jia Xiangbo, Qian Rulin, Zhang Binbin, Zhao So |
| Comparison of small biopsy specimens and surgical specimens for the detection of EGFR mutations and EML4-ALK in non-small-cell lung cancer. Oncotarget 2016 Jun . Xiao DeSheng, Lu Can, Zhu Wei, He QiuYan, Li Yong, Fu ChunYan, Zhou JianHua, Liu Shuang, Tao YongGua |
| Distinct epithelial growth factor receptor mutation profile in non-small-cell lung cancer patients from the Xuanwei area of China. Molecular and clinical oncology 2016 May 4 (5): 749-755. Chen Yun, Ye Lijuan, Stanford Rebecca Rongrong, Zhang Dongfang, Zhang Xingsong, Wei Wan |
| Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr . Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu |
| [Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma]. Revue des maladies respiratoires 2016 Mar . Fournier C, Greillier L, Fina F, Secq V, Nanni-Metellus I, Loundou A, Garcia S, Ouafik L, Tomasini P, Barlesi |
| Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer. OncoTargets and therapy 2016 9 1989-95. Wen Miaomiao, Wang Xuejiao, Sun Ying, Xia Jinghua, Fan Liangbo, Xing Hao, Zhang Zhipei, Li Xiaof |
| Phenotype-genotype correlation in multiple primary lung cancer patients in China. Scientific reports 2016 10 6 36177. Yang Yang, Yin Wei, He Wenxin, Jiang Chao, Zhou Xiao, Song Xiao, Zhu Junjie, Fei Ke, Cao Weijun, Jiang Geni |
| Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma. Journal of translational medicine 2016 06 14 (1): 188. Song Zhengbo, Yu Xinmin, Cheng Guoping, Zhang Yipi |
- Page last reviewed:Oct 1, 2021
- Page last updated:Oct 13, 2021
- Content source: